Radiation Therapy Quality Assurance in Clinical Trials

Radiation therapy (RT) is a cornerstone treatment for cancer and frequently employed in clinical trials to explore novel systemic therapy agents in both curative and non-curative settings. The sophistication of RT provides patients with access to treatments with high levels of accuracy and precision as well as reduced toxicity, if employed correctly. However, the inherent complexity of RT planning and delivery requires rigorous quality assurance to reduce practice variability, minimize suboptimal treatments, and ensure safe and effective patient care.

The purpose of this white paper is to highlight the fundamental role that RT plays in cancer treatment and its growing importance in the context of oncology clinical trials. This will include a review of the major sources of variability in RT, which can result in suboptimal treatment with a potential to adversely impact patient outcomes and study results. Finally, this white paper defines the key elements of a radiation therapy quality management program along with a guideline for practical prospective implementation into pharmaceutical clinical trials.

Oncology & Hematology

Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.

To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Related solutions